These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 11830758)
1. Recent developments in the discovery of novel adenosine kinase inhibitors: mechanism of action and therapeutic potential. McGaraughty S; Cowart M; Jarvis MF CNS Drug Rev; 2001; 7(4):415-32. PubMed ID: 11830758 [TBL] [Abstract][Full Text] [Related]
2. Anticonvulsant and antinociceptive actions of novel adenosine kinase inhibitors. McGaraughty S; Cowart M; Jarvis MF; Berman RF Curr Top Med Chem; 2005; 5(1):43-58. PubMed ID: 15638777 [TBL] [Abstract][Full Text] [Related]
5. Discovery of 4-amino-5-(3-bromophenyl)-7-(6-morpholino-pyridin-3-yl)pyrido[2,3-d]pyrimidine, an orally active, non-nucleoside adenosine kinase inhibitor. Lee CH; Jiang M; Cowart M; Gfesser G; Perner R; Kim KH; Gu YG; Williams M; Jarvis MF; Kowaluk EA; Stewart AO; Bhagwat SS J Med Chem; 2001 Jun; 44(13):2133-8. PubMed ID: 11405650 [TBL] [Abstract][Full Text] [Related]
6. ABT-702 (4-amino-5-(3-bromophenyl)-7-(6-morpholinopyridin-3-yl)pyrido[2, 3-d]pyrimidine), a novel orally effective adenosine kinase inhibitor with analgesic and anti-inflammatory properties: I. In vitro characterization and acute antinociceptive effects in the mouse. Jarvis MF; Yu H; Kohlhaas K; Alexander K; Lee CH; Jiang M; Bhagwat SS; Williams M; Kowaluk EA J Pharmacol Exp Ther; 2000 Dec; 295(3):1156-64. PubMed ID: 11082453 [TBL] [Abstract][Full Text] [Related]
7. ABT-702 (4-amino-5-(3-bromophenyl)-7-(6-morpholino-pyridin- 3-yl)pyrido[2,3-d]pyrimidine), a novel orally effective adenosine kinase inhibitor with analgesic and anti-inflammatory properties. II. In vivo characterization in the rat. Kowaluk EA; Mikusa J; Wismer CT; Zhu CZ; Schweitzer E; Lynch JJ; Lee CH; Jiang M; Bhagwat SS; Gomtsyan A; McKie J; Cox BF; Polakowski J; Reinhart G; Williams M; Jarvis MF J Pharmacol Exp Ther; 2000 Dec; 295(3):1165-74. PubMed ID: 11082454 [TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and structure-activity relationship of 6-alkynylpyrimidines as potent adenosine kinase inhibitors. Gomtsyan A; Didomenico S; Lee CH; Matulenko MA; Kim K; Kowaluk EA; Wismer CT; Mikusa J; Yu H; Kohlhaas K; Jarvis MF; Bhagwat SS J Med Chem; 2002 Aug; 45(17):3639-48. PubMed ID: 12166937 [TBL] [Abstract][Full Text] [Related]
9. Analgesic and anti-inflammatory effects of A-286501, a novel orally active adenosine kinase inhibitor. Jarvis MF; Yu H; McGaraughty S; Wismer CT; Mikusa J; Zhu C; Chu K; Kohlhaas K; Cowart M; Lee CH; Stewart AO; Cox BF; Polakowski J; Kowaluk EA Pain; 2002 Mar; 96(1-2):107-18. PubMed ID: 11932067 [TBL] [Abstract][Full Text] [Related]